Friday, 17 Nov 2017

You are here

My ACR Takeaways

With ACR 2017 winding down and the sheer volume of information seemingly overwhelming, I wanted to take the time to write an article regarding a few tips I learned that I will use in clinical practice. 

1. With regards to the flu vaccine, holding MTX for two weeks after the flu vaccine will increase immunogenicity without worsening disease. 
2. CAPS is a complementopathy and Eculizumab (anti-C5a) is approved for treatment, though is expensive
3. 1% of GPA patients can present with pituitary involvement and respond to Cytoxan or Rituxan
4. HCQ should be a mainstay in APS therapy – can reduce size of thrombus and number of potential events. 
5. MMF at 3 grams is not superior to 2 grams in rheum-related ILD
6. RA and SpA remission patients fare better with continued therapy than with withdrawal 
7. A healthy mom is the best thing for a healthy baby in terms of safety of continuing DMARDs and bDMARDs during pregnancy and lactation. 
8. Options for MACRA and MIPs data submission supported by ACR include the RISE registry and RCR

While this list barely scratches the surface, it’s a helpful start to digesting data from ACR to use for our day to day practice. I’m looking forward to hearing more about upcoming guidelines, updated diagnostic criteria, telemedicine, and US advances in both the education and diagnostic realms. 

Until Chicago!

 


Rheumatologists' Comments

Dear Rachel Tate, it´s a fantastic compilation of the ACR on what we should start (or keep) doing. Congratulations, Carlos Antonio Moura

More Like This

The RheumNow Week in Review - 17 November 2017

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com. This week he covers FDA warnings on gout drugs, steroid use in Australia, biosimilars lost savings and methotrexate hepatotoxicity in psoriatic arthritis (PsA).

Podcast of ACR17 - Day 4

Care to learn what you missed at last weeks ACR 2017 meeting in San Diego?  Here are 4 one hour audio podcasts - each with a compliation of 2-4 minute reports from Drs. Cush, Kavanaugh, the RheumNow Faculty and other rheumatology thought leaders and researchers.  Another good way to learn from RheumNow.

The ACR17 RheumNow Week in Review - 10 November 2017

This special edition of the RheumNow Week in Review covers highlights of selected sessions from the 2017 ACR annual meeting in San Diego. Dr. Jack Cush reviews lupus and the microbiome, daily podcasts, pregnancy and lactation, osteoporosis drug holidays and screening for pulmonary hypertension.

Many thanks to the RheumNow Faculty for their work and expertise!

Podcast of ACR 17 - Day 3

Check out this compilation of our ACR17 Day 3 broadcasts, merged into a single one hour podcast !

ACR 2017 - Day 3 and 4 Highlights

Day 3 at the annual meeting was rich with information. Yet the most anticipated and best attended session was the Late Breaking Abstracts and the session revealing the new ACR/NPF Guidelines for Psoriatic Arthritis (more on the latter in another report).  Day 4 was full of review sessions and a modicum of original content and for me, the 7:30AM Rheumatology Roundup.